International Consensus Statement on the Clinical and Therapeutic Management of Leber Hereditary Optic Neuropathy

Abstract: Leber hereditary optic neuropathy (LHON) is currently estimated as the most frequent mitochondrial disease (1 in 27,000–45,000). Its molecular pathogenesis and natural history is now fairly well understood. LHON also is the first mitochondrial disease for which a treatment has been approved (idebenone–Raxone, Santhera Pharmaceuticals) by the European Medicine Agency, under exceptional circumstances because of the rarity and severity of the disease. However, what remains unclear includes the optimal target population, timing, dose, and frequency of administration of idebenone in LHON due to lack of accepted definitions, criteria, and general guidelines for the clinical management of LHON. To address these issues, a consensus conference with a panel of experts from Europe and North America was held in Milan, Italy, in 2016. The intent was to provide expert consensus statements for the clinical and therapeutic management of LHON based on the currently available evidence. We report the conclusions of this conference, providing the guidelines for clinical and therapeutic management of LHON.

[1]  P. Yu-Wai-Man,et al.  Evaluating the therapeutic potential of idebenone and related quinone analogues in Leber hereditary optic neuropathy , 2017, Mitochondrion.

[2]  P. Barboni,et al.  A neurodegenerative perspective on mitochondrial optic neuropathies , 2016, Acta Neuropathologica.

[3]  P. Chinnery,et al.  Reply: Parsing the differences in affected with LHON: genetic versus environmental triggers of disease conversion. , 2016, Brain : a journal of neurology.

[4]  C. La Morgia,et al.  Cigarette toxicity triggers Leber's hereditary optic neuropathy by affecting mtDNA copy number, oxidative phosphorylation and ROS detoxification pathways , 2015, Cell Death and Disease.

[5]  G. Savini,et al.  Macular nerve fibre and ganglion cell layer changes in acute Leber's hereditary optic neuropathy , 2015, British Journal of Ophthalmology.

[6]  Robert W. Taylor,et al.  Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease , 2015, Annals of neurology.

[7]  P. Chinnery,et al.  Leber’s hereditary optic neuropathy with late disease onset: clinical and molecular characteristics of 20 patients , 2014, Orphanet Journal of Rare Diseases.

[8]  C. La Morgia,et al.  Genetic Basis of Mitochondrial Optic Neuropathies. , 2014, Current molecular medicine.

[9]  M. Votruba,et al.  Treatment strategies for inherited optic neuropathies: past, present and future , 2014, Eye.

[10]  Jorn-Hon Liu,et al.  Leber's hereditary optic neuropathy masquerading as optic neuritis with spontaneous visual recovery , 2014, Clinical & experimental optometry.

[11]  M. Zeviani,et al.  Efficient mitochondrial biogenesis drives incomplete penetrance in Leber’s hereditary optic neuropathy , 2013, Brain : a journal of neurology.

[12]  T. Klopstock,et al.  Effects of Idebenone on Color Vision in Patients With Leber Hereditary Optic Neuropathy , 2013, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[13]  V. Carelli,et al.  Mathematically modeling the involvement of axons in Leber's hereditary optic neuropathy. , 2012, Investigative ophthalmology & visual science.

[14]  N. Newman.  Treatment of hereditary optic neuropathies , 2012, Nature Reviews Neurology.

[15]  J. Sebag,et al.  Neuron-specific enolase is elevated in asymptomatic carriers of Leber's hereditary optic neuropathy. , 2012, Investigative ophthalmology & visual science.

[16]  N. Gueven,et al.  Idebenone Protects against Retinal Damage and Loss of Vision in a Mouse Model of Leber’s Hereditary Optic Neuropathy , 2012, PloS one.

[17]  P. Chinnery,et al.  Persistence of the treatment effect of idebenone in Leber’s hereditary optic neuropathy , 2012, Brain : a journal of neurology.

[18]  M. Zeviani,et al.  Rare Primary Mitochondrial DNA Mutations and Probable Synergistic Variants in Leber’s Hereditary Optic Neuropathy , 2012, PloS one.

[19]  B. Mascialino,et al.  Meta-analysis of the prevalence of Leber hereditary optic neuropathy mtDNA mutations in Europe , 2012, European journal of ophthalmology.

[20]  N. Gueven,et al.  Features of Idebenone and Related Short-Chain Quinones that Rescue ATP Levels under Conditions of Impaired Mitochondrial Complex I , 2012, PloS one.

[21]  W. Feuer,et al.  Retinal Nerve Fiber Layer Thickness Variability in Leber Hereditary Optic Neuropathy Carriers , 2012, European journal of ophthalmology.

[22]  V. Giorgio,et al.  The effects of idebenone on mitochondrial bioenergetics , 2012, Biochimica et biophysica acta.

[23]  D. Milea,et al.  Idebenone increases mitochondrial complex I activity in fibroblasts from LHON patients while producing contradictory effects on respiration , 2011, BMC Research Notes.

[24]  N. Newman.  Treatment of Leber hereditary optic neuropathy. , 2011, Brain : a journal of neurology.

[25]  A. Tselis,et al.  Leber hereditary optic neuropathy mimicking neuromyelitis optica. , 2011, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[26]  P. Chinnery,et al.  A randomized placebo-controlled trial of idebenone in Leber’s hereditary optic neuropathy , 2011, Brain : a journal of neurology.

[27]  Giovanni Rizzo,et al.  Idebenone treatment in Leber's hereditary optic neuropathy. , 2011, Brain : a journal of neurology.

[28]  P. Chinnery,et al.  Mitochondrial optic neuropathies – Disease mechanisms and therapeutic strategies , 2011, Progress in Retinal and Eye Research.

[29]  N. Newman.  Leber hereditary optic neuropathy: bad habits, bad vision? , 2009, Brain : a journal of neurology.

[30]  P. Chinnery,et al.  Gene–environment interactions in Leber hereditary optic neuropathy , 2009, Brain : a journal of neurology.

[31]  G. Savini,et al.  Association of optic disc size with development and prognosis of Leber's hereditary optic neuropathy. , 2009, Investigative ophthalmology & visual science.

[32]  V. Carelli,et al.  Male prevalence of acquired color vision defects in asymptomatic carriers of Leber's hereditary optic neuropathy. , 2007, Investigative ophthalmology & visual science.

[33]  G. Savini,et al.  Leber's hereditary optic neuropathy with childhood onset. , 2006, Investigative ophthalmology & visual science.

[34]  M. T. Bhatti,et al.  Progression of visual field defects in leber hereditary optic neuropathy: experience of the LHON treatment trial. , 2006, American journal of ophthalmology.

[35]  V. Carelli,et al.  Colour vision defects in asymptomatic carriers of the Leber’s hereditary optic neuropathy (LHON) mtDNA 11778 mutation from a large Brazilian LHON pedigree: a case-control study , 2006, British Journal of Ophthalmology.

[36]  V. Carelli,et al.  Mitochondrial dysfunction as a cause of optic neuropathies , 2004, Progress in Retinal and Eye Research.

[37]  V. Carelli,et al.  Extensive investigation of a large Brazilian pedigree of 11778/haplogroup J Leber hereditary optic neuropathy. , 2003, American journal of ophthalmology.

[38]  M. Wakakura,et al.  Do Idebenone and Vitamin Therapy Shorten the Time to Achieve Visual Recovery in Leber Hereditary Optic Neuropathy? , 2000, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[39]  P. Barboni,et al.  Leber's Hereditary Optic Neuropathy (LHON) with 14484/ND6 mutation in a North African patient , 1998, Journal of the Neurological Sciences.

[40]  P. Zaniol,et al.  Clinical and brain bioenergetics improvement with idebenone in a patient with Leber's hereditary optic neuropathy: a clinical and 31P-MRS study , 1997, Journal of the Neurological Sciences.

[41]  K. Huoponen,et al.  Ophthalmologic findings in Leber hereditary optic neuropathy, with special reference to mtDNA mutations. , 1996, Ophthalmology.

[42]  M. Sanders,et al.  The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation. , 1995, Brain : a journal of neurology.

[43]  N. Miller,et al.  Leber's hereditary optic neuropathy masquerading as tobacco-alcohol amblyopia. , 1993, Archives of ophthalmology.

[44]  Y. Mashima,et al.  Remission of Leber's hereditary optic neuropathy with idebenone , 1992, The Lancet.

[45]  N. Newman,et al.  Visual recovery in patients with Leber's hereditary optic neuropathy and the 11778 mutation. , 1992, Journal of clinical neuro-ophthalmology.

[46]  D. Wallace,et al.  Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. , 1988, Science.

[47]  W. Hoyt,et al.  Ophthalmoscopic findings in Leber's hereditary optic neuropathy. II. The fundus findings in the affected family members. , 1983, Archives of ophthalmology.

[48]  W. Hoyt,et al.  Ophthalmoscopic findings in Leber's hereditary optic neuropathy. I. Fundus findings in asymptomatic family members. , 1982, Archives of ophthalmology.

[49]  Erickson Rp.  Leber's optic atrophy, a possible example of maternal inheritance. , 1972 .

[50]  P. Barboni,et al.  Parsing the differences in affected with LHON: genetic versus environmental triggers of disease conversion. , 2016, Brain : a journal of neurology.

[51]  A. Martinuzzi,et al.  Oestrogens ameliorate mitochondrial dysfunction in Leber's hereditary optic neuropathy. , 2011, Brain : a journal of neurology.

[52]  R. Sergott.  Natural History of Leber's Hereditary Optic Neuropathy: Longitudinal Analysis of the Retinal Nerve Fiber Layer by Optical Coherence Tomography , 2010 .

[53]  G. Savini,et al.  Retinal nerve fiber layer evaluation by optical coherence tomography in unaffected carriers with Leber's hereditary optic neuropathy mutations. , 2005, Ophthalmology.

[54]  G. Savini,et al.  Retinal nerve fiber layer evaluation by optical coherence tomography in Leber's hereditary optic neuropathy. , 2005, Ophthalmology.

[55]  R. Erickson.  Leber's optic atrophy, a possible example of maternal inheritance. , 1972, American journal of human genetics.